News & Updates

January 20, 2022

PyrAmes Technology Featured in Neonatal Intensive Care Journal

The PyrAmes Boppli™ device is featured on page 11 in the Winter 2022 edition of Neonatal Intensive Care: The Journal of Perinatology-Neonatology. The article focuses on how the Boppli is being developed to meet the need for continuous, non-invasive blood pressure monitoring in the neonatal intensive care unit (NICU).
April 20, 2021

PyrAmes Raises $6 Million in Series A Financing

Cupertino, CA, -- (Marketwired - April 20, 2021) – PyrAmes, Inc., a digital healthcare company focused on innovative products for continuous blood pressure monitoring, today announced the completion of a $6 million Series A financing. The investment round was led by GSR Ventures, with co-investments from Keytone Ventures, XTX Ventures and other investors. (more…)
May 18, 2020

FDA Breakthrough Device Designation

PyrAmes Inc. is proud to announce that the FDA has granted Breakthrough Device Designation (BDD) to Boppli™, which fills the unmet need of monitoring the blood pressure of critically ill infants when an invasive arterial catheter cannot be used due to the risk of complications and adverse effects. (more…)
April 15, 2020

SWPDC Pediatric Device Award

PyrAmes is honored to be selected by the Southwest National Pediatric Device Innovation Consortium (SWPDC) as a winner of the SWPDC Spring Competition. The SouthWest National Pediatric Device Innovation Consortium (SWPDC) is a “free no-strings-attached” virtual accelerator based at Texas Children’s Hospital and Baylor College of Medicine that supports pediatric device innovators nationwide throughout the pediatric device life cycle. The goal of the SWPDC is to accelerate commercialization and clinical use of novel pediatric devices.
April 1, 2020

PyrAmes Awarded SBIR Phase I Grant from NIH

PyrAmes is pleased to announce it has been awarded a Phase I grant from the National Institutes of Health. The Grant will be used for ongoing product development as well as clinical validation studies. A key objective of the NIH Grant Program is to facilitate development of promising medical technologies. The content of this announcement is solely the responsibility of the author and does not necessarily represent the official views of the NIH.
February 18, 2020

Founding Member of CDC National Hypertension Control Roundtable

With hypertension reaching record levels, PyrAmes has joined with the Centers for Disease Control (CDC) in the formation of the National Hypertension Control Roundtable. The Roundtable was formed in 2020 along with 50 other organizations committed to reversing this trend. Nearly half of adults in the US suffer from hypertension, but only about 1 in 4 cases are well-managed. The US Surgeon General has issued a “Call to Action” to make hypertension control a national priority and to optimize patient care for hypertension.
December 16, 2019

PyrAmes Awarded SBIR Phase I Grant from USAF

PyrAmes is pleased to announce it has been awarded a Phase I grant from the United States Air Force (USAF) AFWERX program. Pyrames was part of a select group of companies asked to undertake a feasibility study to determine product viability within the Department of Defense (DoD). AFWERX is a program within the USAF and was formed in 2017 as a vehicle to fuel innovation within the private sector. The ultimate goal of the program is to address unmet needs and enhance the effectiveness of the Air Force.
November 6, 2019

One to Watch Award Exponential Medicine

Xina Quan, Co-founder and CEO of PyrAmes, accepted the One to Watch Award from Exponential Medicine. You can watch her acceptance presentation to the attendees starting at the 11:35 mark below. Exponential Medicine is an annual conference run by Singularity University, that provides leading scientists, inventors and thought leaders a forum to present and discuss the very latest in innovation. (more…)
October 18, 2019

Winner of Texas HALO FUND Corona Award (Ignite Fire Pitch Competition)

At Ignite Healthcare Networks’ third annual Pitch Competition, PyrAmes was awarded a Texas HALO FUND Corona Award.  The 10-week mini-accelerator program featured eight women-led digital health startup companies from Texas, California and Australia, and provided support to the businesses through $220,000 in cash prizes and investments, as well as mentorship from industry experts, investors and potential customers.
September 26, 2019

2019 Winner of the NCC Pediatric Device Pitch Competition

PyrAmes was one of six pediatric device companies to win the “Make Your Medical Device Pitch for Kids!” program during the 7th Annual Pediatric Device Innovation Symposium. The program was developed to assist medical device companies in improving care in the Neonatal Intensive Care Unit (NICU). The Symposium is sponsored by Children’s National Hospital and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).